Pain
Article
Poll: How have you changed opioid prescribing in your practice?
How have you changed opioid prescribing in your practice?
Hitting a Nerve
Risks of keeping controlled substances in office tilt away from benefits
Keeping controlled substances in his office isn’t worth the hassle or risk, Dr. Allan M. Block says.
News from the FDA/CDC
FDA asks drug maker to shelve Opana ER
This marks the first time the agency has acted to remove an opioid pain medication because of the public health consequences of abuse.
Conference Coverage
VIDEO: Phase III results show promise for erenumab as migraine prevention drug
BOSTON – The drug aims to be “the first mechanism-specific, migraine-targeted preventive treatment approach ever.”
Conference Coverage
ACT2: Noninvasive vagus nerve stimulation benefits episodic cluster headache
BOSTON – Noninvasive vagus nerve stimulation proved safe and effective for the treatment of episodic cluster headaches.
Conference Coverage
VIDEO: Big research trials at AAN bring up important cost decisions
BOSTON – How will neurologists strike a balance between new drugs’ improved efficacy and safety and their affordability for patients?
Conference Coverage
Does Gender Influence Pain Sensitivity?
STOWE, VT—Mounting evidence suggests that gender affects the modulation of pain to a greater extent than has been understood, according to an...
Conference Coverage
After the epidemic, Ebola’s destructive power still haunts survivors
VIENNA – Nearly 80% of survivors in Sierra Leone now appear to have one or more sequelae of the infection – some so debilitating that life may...
FDA/CDC
FDA approves new treatment for episodic cluster headaches in adults
The Food and Drug Administration announced April 18 the approval of the gammaCore device to treat pain associated with episodic cluster headache...
Conference Coverage
Bevy of monoclonal antibody migraine prevention trials awaits attendees
Investigators are set to present results from trials for the calcitonin gene–related peptide monoclonal antibodies erenumab and eptinezumab.
From the Journals
Lifetime headache, suicide attempts may be linked in older patients
In elderly patients, an association is found between a risk of lifetime headache and lifetime suicide attempts.